Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Short-Term Debt issuances (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Short-Term Debt issuances for 17 consecutive years, with -$426.0 million as the latest value for Q3 2025.

  • Quarterly Short-Term Debt issuances rose 82.84% to -$426.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$405.0 million through Sep 2025, down 249.45% year-over-year, with the annual reading at $99.0 million for FY2024, N/A changed from the prior year.
  • Short-Term Debt issuances for Q3 2025 was -$426.0 million at Bristol Myers Squibb, down from $58.0 million in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $3.0 billion in Q1 2024, with the low at -$2.5 billion in Q3 2024.
  • Average Short-Term Debt issuances over 5 years is -$3.4 million, with a median of -$34.0 million recorded in 2022.
  • Peak annual rise in Short-Term Debt issuances hit 2233.59% in 2024, while the deepest fall reached 24730.0% in 2024.
  • Over 5 years, Short-Term Debt issuances stood at -$114.0 million in 2021, then surged by 49.12% to -$58.0 million in 2022, then crashed by 301.72% to -$233.0 million in 2023, then plummeted by 73.82% to -$405.0 million in 2024, then dropped by 5.19% to -$426.0 million in 2025.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at -$426.0 million, $58.0 million, and $368.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.